The potential role of nutritional components in the management of Alzheimer's Disease

European Journal of Pharmacology

Volumn 585, Issue 1, 2008, Pages 197-207

  van der Beek, Eline M ^a   Kamphuis, Patrick J G H ^a  

^a NUMICO RESEARCH   (Netherlands)

Author keywords

Alzheimer; Nutritional intervention; Synapse formation

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID;

ALZHEIMER DISEASE; BRAIN FUNCTION; HUMAN; MACRONUTRIENT; NERVE CELL PLASTICITY; NUTRITION; NUTRITIONAL DEFICIENCY; PRIORITY JOURNAL; REVIEW;

AGING; ALZHEIMER DISEASE; ANTIOXIDANTS; BRAIN; FATTY ACIDS, OMEGA-3; HUMANS; NUTRITION THERAPY; SYNAPSES; VITAMINS;

EID: 42249110870     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.01.049     Document Type: Review

References (136)

1. Abad-Rodriguez J., Ledesma M.D., Craessaerts K., Perga S., Medina M., Delacourte A., Dingwall C., De Strooper B., and Dotti C.G. Neuronal membrane cholesterol loss enhances amyloid peptide generation. J. Cell Biol. 167 (2004) 953-960
2. Adalbert R., Gilley J., and Coleman M.P. Abeta, tau and ApoE4 in Alzheimer's disease: the axonal connection. Trends Mol. Med. 13 (2007) 135-142
3. Ailhaud G., and Guesnet P. Fatty acid composition of fats is an early determinant of childhood obesity: a short review and an opinion. Obes. Rev. 5 (2004) 21-26
4. Aminbakhsh A., and Mancini G.B. Carotid intima-media thickness measurements: what defines an abnormality? A systematic review. Clin. Invest. Med. 22 (1999) 149-157
5. Araki W., and Wurtman R.J. How is membrane phospholipid biosynthesis controlled in neural tissues?. J. Neurosci. Res. 51 (1998) 667-674
6. Austin R.C., Lentz S.R., and Werstuck G.H. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease. Cell Death Differ. 11 (2004) S56-S64
7. Bedard M., Molloy D.W., Bell R., and Lever J.A. Determinants and detection of low body mass index in community-dwelling adults with Alzheimer's disease. Int. Psychogeriatr. 12 (2000) 87-98
8. Bourre J.M. Roles of unsaturated fatty acids (especially omega-3 fatty acids) in the brain at various ages and during ageing. J. Nutr. Health Aging. 8 (2004) 163-174
9. Bourre J.M. Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 1: micronutrients. J. Nutr. Health Aging. 10 (2006) 377-385
10. Bourre J.M. Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 2: macronutrients. J. Nutr. Health Aging. 10 (2006) 386-399
11. Broersen L.M., De Wilde M.C., Kuipers A., Leenders I., Kamphuis P.J., and van der Beek E.M. Reduced beta-amyloid plaque burden and neurodegeneration in APP/PS1 transgenic mice following multi-nutrient dietary intervention. Soc. Neurosci. Abstr. 157 (2007) 16
12. Buee L., Bussiere T., Buee-Scherrer V., Delacourte A., and Hof P.R. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Brain Res. Rev. 33 (2000) 95-130
13. Buttini M., Yu G.Q., Shockley K., Huang Y., Jones B., Masliah E., Mallory M., Yeo T., Longo F.M., and Mucke L. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation. J. Neurosci. 22 (2002) 10539-10548
14. Caceres A., and Kosik K.S. Inhibition of neurite polarity by tau antisense oligonucleotides in primary cerebellar neurons. Nature. 343 (1990) 461-463
15. Calon F., Lim G.P., Yang F., Morihara T., Teter B., Ubeda O., Rostaing P., Triller A., Salem Jr. N., Ashe K.H., Frautschy S.A., and Cole G.M. Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron. 43 (2004) 633-645
16. Cansev M., Watkins C.J., van der Beek E.M., and Wurtman R.J. Oral uridine-5′-monophosphate (UMP) increases brain CDP-choline levels in gerbils. Brain Res. 1058 (2005) 101-108
17. Cansev M., and Wurtman R.J. Aromatic amino acids in the brain. Handb. Neurochem. Mol. Neurobiol. 6 (2007) 60-97
18. Cansev M., and Wurtman R.J. Chronic administration of docosahexaenoic acid or eicosapentaenoic acid, but not arachidonic acid, alone or in combination with uridine, increases brain phosphatide and synaptic protein levels in gerbils. Neuroscience 31 (2007) 421-431
19. Chambers J.C., Ueland P.M., Obeid O.A., Wrigley J., Refsum H., and Kooner J.S. Improved vascular endothelial function after oral B vitamins: an effect mediated through reduced concentrations of free plasma homocysteine. Circulation. 102 (2000) 2479-2483
20. Claassen J.A., and Jansen R.W. Cholinergically mediated augmentation of cerebral perfusion in Alzheimer's disease and related cognitive disorders: the cholinergic-vascular hypothesis. J. Gerontol. A Biol. Sci. Med. Sci. 61 (2006) 267-271
21. Clandinin M.T., Suh M., and Hargreaves K. Impact of dietary fatty acid balance on membrane structure and function of neuronal tissues. Adv. Exp. Med. Biol. 318 (1992) 197-210
22. Cohen E.L., and Wurtman R.J. Brain acetylcholine: control by dietary choline. Science. 191 (1976) 561-562
23. Cole G.M., Lim G.P., Yang F., Teter B., Begum A., Ma Q., Harris-White M.E., and Frautschy S.A. Prevention of Alzheimer's disease: omega-3 fatty acid and phenolic anti-oxidant interventions. Neurobiol. Aging 26 Suppl. 1 (2005) 133-136
24. Coleman P., Federoff H., and Kurlan R. A focus on the synapse for neuroprotection in Alzheimer disease and other dementias. Neurology. 63 (2004) 1155-1162
25. Conquer J.A., Tierney M.C., Zecevic J., Bettger W.J., and Fisher R.H. Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment. Lipids 35 (2000) 1305-1312
26. Cordy J.M., Hooper N.M., and Turner A.J. The involvement of lipid rafts in Alzheimer's disease. Mol. Membr. Biol. 23 (2006) 111-122
27. Davies P., and Maloney A.J. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet. 2 (1976) 1403
28. De Bruin N.M., Kiliaan A.J., De Wilde M.C., and Broersen L.M. Combined uridine and choline administration improves cognitive deficits in spontaneously hypertensive rats. Neurobiol. Learn Mem. 80 (2003) 63-79
29. de Lau L.M., Refsum H., Smith A.D., Johnston C., and Breteler M.M. Plasma folate concentration and cognitive performance: Rotterdam Scan Study. Am. J. Clin. Nutr. 86 (2007) 728-734
30. de Wilde M.C., Farkas E., Gerrits M., Kiliaan A.J., and Luiten P.G. The effect of n-3 polyunsaturated fatty acid-rich diets on cognitive and cerebrovascular parameters in chronic cerebral hypoperfusion. Brain Res. 947 (2002) 166-173
31. de Wilde M.C., Hogyes E., Kiliaan A.J., Farkas T., Luiten P.G., and Farkas E. Dietary fatty acids alter blood pressure, behavior and brain membrane composition of hypertensive rats. Brain Res. 988 (2003) 9-19
32. Dietschy J.M., and Turley S.D. Thematic review series: brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J. Lipid Res. 45 (2004) 1375-1397
33. Dubois B., Feldman H.H., Jacova C., Dekosky S.T., Barberger-Gateau P., Cummings J., Delacourte A., Galasko D., Gauthier S., Jicha G., Meguro K., O'Brien J., Pasquier F., Robert P., Rossor M., Salloway S., Stern Y., Visser P.J., and Scheltens P. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 6 (2007) 610-617
34. Duering M., Grimm M.O., Grimm H.S., Schroder J., and Hartmann T. Mean age of onset in familial Alzheimer's disease is determined by amyloid beta 42. Neurobiol. Aging. 26 (2005) 785-788
35. Eastley R., Wilcock G.K., and Bucks R.S. Vitamin B12 deficiency in dementia and cognitive impairment: the effects of treatment on neuropsychological function. Int. J. Geriatr. Psychiatry. 15 (2000) 226-233
36. Engelhart M.J., Geerlings M.I., Ruitenberg A., van Swieten J.C., Hofman A., Witteman J.C., and Breteler M.M. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 287 (2002) 3223-3229
37. Farkas E., de Wilde M.C., Kiliaan A.J., Meijer J., Keijser J.N., and Luiten P.G. Dietary long chain PUFAs differentially affect hippocampal muscarinic 1 and serotonergic 1A receptors in experimental cerebral hypoperfusion. Brain Res. 954 (2002) 32-41
38. Fassbender K., Simons M., Bergmann C., Stroick M., Lutjohann D., Keller P., Runz H., Kuhl S., Bertsch T., von Bergmann K., Hennerici M., Beyreuther K., and Hartmann T. Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc. Natl. Acad. Sci.U.S.A. 98 (2001) 5856-5861
39. Faxen-Irving G., Andren-Olsson B., af Geijerstam G., Basun H., and Cederholm T. The effect of nutritional intervention in elderly subjects residing in group-living for the demented. Eur. J. Clin. Nutr. 56 (2002) 221-227
40. Fernstrom J.D. Dietary precursors and brain neurotransmitter formation. Annu. Rev. Med. 32 (1981) 413-425
41. Fleith M., and Clandinin M.T. Dietary PUFA for preterm and term infants: review of clinical studies. Crit. Rev. Food Sci. Nutr. 45 (2005) 205-229
42. Flicker L., Martins R.N., Thomas J., Psych J.A., Taddei K., Vasikaran S.D., Norman P., Jamrozik K., and Almeida O.P. B-vitamins reduce plasma levels of beta amyloid. Neurobiol. Aging 17 (2006) 17-19
43. Freund-Levi Y., Eriksdotter-Jonhagen M., Cederholm Y., Basun H., Faxen-Irving G., Garlind A., Vedin I., Vessby B., Wahlund L.O., and Palmblad J. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch. Neurol. 63 (2006) 1402-1408
44. Fryer J.D., Simmons K., Parsadanian M., Bales K.R., Paul S.M., Sullivan P.M., and Holtzman D.M. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model. J. Neurosci. 25 (2005) 2803-2810
45. Gentile M.T., Poulet R., Pardo A.D., Cifelli G., Maffe A.i., Vecchione C., Passarelli F., Landolfi A., Carullo P., and Lembo G. beta-Amyloid deposition in brain is enhanced in mouse models of arterial hypertension. Neurobiol. Aging 26 (2007) 26-32
46. Gillette Guyonnet S., Abellan Van Kan G., Andrieu S., Barberger Gateau P., Berr C., Bonnefoy M., Dartigues J.F., de Groot L., Ferry M., Galan P., Hercberg S., Jeandel C., Morris M.C., Nourhashemi F., Payette H., Poulain J.P., Portet F., Roussel A.M., Ritz P., Rolland Y., and Vellas B. IANA task force on nutrition and cognitive decline with aging. J. Nutr. Health Aging. 11 (2007) 132-152
47. Green K.N., Martinez-Coria H., Khashwji H., Hall E.B., Yurko-Mauro K.A., Ellis L., and LaFerla F.M. Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-beta and tau pathology via a mechanism involving presenilin 1 levels. J. Neurosci. 27 (2007) 4385-4395
48. Greenwood C.E., and Winocur G. High-fat diets, insulin resistance and declining cognitive function. Neurobiol. Aging 26 Suppl. 1 (2005) 42-45
49. Harris W.S. n-3 fatty acids and lipoproteins: comparison of results from human and animal studies. Lipids. 31 (1996) 243-252
50. Hashimoto M., Hossain S., Shimada T., Sugioka K., Yamasaki H., Fujii Y., Ishibashi Y., Oka J., and Shido O. Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer's disease model rats. J. Neurochem. 81 (2002) 1084-1091
51. Hashimoto M., Tanabe Y., Fujii Y., Kikuta T., Shibata H., and Shido O. Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid beta-infused rats. J. Nutr. 135 (2005) 549-555
52. Himmler A., Drechsel D., Kirschner M.W., and Martin Jr. D.W. Tau consists of a set of proteins with repeated C-terminal microtubule-binding domains and variable N-terminal domains. Mol. Cell Biol. 9 (1989) 1381-1388
53. Ho L., Qin W., Pompl P.N., Xiang Z., Wang J., Zhao Z., Peng Y., Cambareri G., Rocher A., Mobbs C.V., Hof P.R., and Pasinetti G.M. Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease. Faseb. J. 18 (2004) 902-904
54. Hooijmans C.R., Rutters F., Dederen P.J., Gambarota G., Veltien A., van Groen T., Broersen L.M., Lutjohann D., Heerschap A., Tanila H., and Kiliaan A.J. Changes in cerebral blood volume and amyloid pathology in aged Alzheimer APP/PS1 mice on a docosahexaenoic acid (DHA) diet or cholesterol enriched Typical Western Diet (TWD). Neurobiol. Dis. 18 (2007) 18-31
55. Horrocks L.A., and Yeo Y.K. Health benefits of docosahexaenoic acid (DHA). Pharmacol. Res. 40 (1999) 211-225
56. Hoyer S. The aging brain. Changes in the neuronal insulin/insulin receptor signal transduction cascade trigger late-onset sporadic Alzheimer disease (SAD). A mini-review. J. Neural. Transm. 109 (2002) 991-1002
57. Iwatsubo T., Odaka A., Suzuki N., Mizusawa H., Nukina N., and Ihara Y. Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron. 13 (1994) 45-53
58. Jhamandas J.H., Cho C., Jassar B., Harris K., MacTavish D., and Easaw J. Cellular mechanisms for amyloid beta-protein activation of rat cholinergic basal forebrain neurons. J. Neurophysiol. 86 (2001) 1312-1320
59. Kalmijn S. Fatty acid intake and the risk of dementia and cognitive decline: a review of clinical and epidemiological studies. J. Nutr. Health Aging. 4 (2000) 202-207
60. Kalmijn S., Launer L.J., Ott A., Witteman J.C., Hofman A., and Breteler M.M. Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann. Neurol. 42 (1997) 776-782
61. Kalmijn S., van Boxtel M.P., Ocke M., Verschuren W.M., Kromhout D., and Launer L.J. Dietary intake of fatty acids and fish in relation to cognitive performance at middle age. Neurology. 62 (2004) 275-280
62. Kar S., Slowikowski S.P., Westaway D., and Mount H.T. Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer's disease. J. Psychiatry Neurosci. 29 (2004) 427-441
63. Kennedy E.P., and Weiss S.B. The function of cytidine coenzymes in the biosynthesis of phospholipides. J. Biol. Chem. 222 (1956) 193-214
64. Kontush A., Mann U., Arlt S., Ujeyl A., Luhrs C., Muller-Thomsen T., and Beisiegel U. Influence of vitamin E and C supplementation on lipoprotein oxidation in patients with Alzheimer's disease. Free Radic Biol. Med. 31 (2001) 345-354
65. Lee H., Kim J.M., Kim H.J., Lee I., and Chang N. Folic acid supplementation can reduce the endothelial damage in rat brain microvasculature due to hyperhomocysteinemia. J. Nutr. 135 (2005) 544-548
66. Lim G.P., Calon F., Morihara T., Yang F., Teter B., Ubeda O., Salem Jr. N., Frautschy S.A., and Cole G.M. A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J. Neurosci. 25 (2005) 3032-3040
67. Luchsinger J.A., Tang M.X., Shea S., and Mayeux R. Caloric intake and the risk of Alzheimer disease. Arch. Neurol. 59 (2002) 1258-1263
68. Luiten P.G., de Jong G.I., Van der Zee E.A., and van Dijken H. Ultrastructural localization of cholinergic muscarinic receptors in rat brain cortical capillaries. Brain Res. 720 (1996) 225-229
69. Martins I.J., Hone E., Foster J.K., Sunram-Lea S.I., Gnjec A., Fuller S.J., Nolan D., Gandy S.E., and Martins R.N. Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease. Mol. Psychiatry. 11 (2006) 721-736
70. Mielke M.M., and Lyketsos C.G. Lipids and the pathogenesis of Alzheimer's disease: is there a link?. Int. Rev. Psychiatry. 18 (2006) 173-186
71. Montiel T., Quiroz-Baez R., Massieu L., and Arias C. Role of oxidative stress on beta-amyloid neurotoxicity elicited during impairment of energy metabolism in the hippocampus: protection by antioxidants. Exp. Neurol. 200 (2006) 496-508
72. Morris M.C., Evans D.A., Bienias J.L., Tangney C.C., Bennett D.A., Aggarwal N., Schneider J., and a Wilson R.S. Dietary fats and the risk of incident Alzheimer disease. Arch. Neurol. 60 (2003) 194-200
73. Morris M.C., Evans D.A., Bienias J.L., Tangney C.C., Bennett D.A., Wilson R.S., Aggarwal N., and Schneider J. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch. Neurol. 60 (2003) 940-946
74. Mulder M., Ravid R., Swaab D.F., de Kloet E.R., Haasdijk E.D., Julk J., van der Boom J.J., and Havekes L.M. Reduced levels of cholesterol, phospholipids, and fatty acids in cerebrospinal fluid of Alzheimer disease patients are not related to apolipoprotein E4. Alzheimer Dis. Assoc. Disord. 12 (1998) 198-955
75. Nilsson K., Gustafson L., and Hultberg B. Improvement of cognitive functions after cobalamin/folate supplementation in elderly patients with dementia and elevated plasma homocysteine. Int. J. Geriatr. Psychiatry. 16 (2001) 609-614
76. Nitsch R.M., Blusztajn J.K., Pittas A.G., Slack B.E., Growdon J.H., and Wurtman R.J. Evidence for a membrane defect in Alzheimer disease brain. Proc. Natl.Acad. Sci. U.S.A. 89 (1992) 1671-1675
77. Obeid R., Kasoha M., Knapp J.P., Kostopoulos P., Becker G., Fassbender K., and Herrmann W. Folate and methylation status in relation to phosphorylated tau protein(181P) and beta-amyloid(1-42) in cerebrospinal fluid. Clin. Chem. 53 (2007) 1129-1136
78. O'Brien J.S., and Sampson E.L. Lipid composition of the normal human brain: gray matter, white matter, and myelin. J. Lipid Res. 6 (1965) 537-544
79. Oddo S., Vasilevko V., Caccamo A., Kitazawa M., Cribbs D.H., and LaFerla F.M. Reduction of soluble Abeta and tau, but not soluble Abeta alone, ameliorates cognitive decline in transgenic mice with plaques and tangles. J. Biol. Chem. 281 (2006) 39413-39423
80. Oksman M., Iivonen H., Hogyes E., Amtul Z., Penke B., Leenders I., Broersen L., Lutjohann D., Hartmann T., and Tanila H. Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice. Neurobiol. Dis. 23 (2006) 563-572
81. Ortega R.M. Importance of functional foods in the Mediterranean diet. Public Health Nutr. 9 (2006) 1136-1140
82. Pettegrew J.W., Panchalingam K., Hamilton R.L., and McClure R.J. Brain membrane phospholipid alterations in Alzheimer's disease. Neurochem. Res. 26 (2001) 771-782
83. Pettegrew J.W., Panchalingam K., Moossy J., Martinez J., Rao G., and Boller F. Correlation of phosphorus-31 magnetic resonance spectroscopy and morphologic findings in Alzheimer's disease. Arch. Neurol. 45 (1988) 1093-1096
84. Pfrieger F.W. Cholesterol homeostasis and function in neurons of the central nervous system. Cell Mol. Life Sci. 60 (2003) 1158-1171
85. Pratico D., Clark C.M., Liun F., Rokach J., Lee V.Y., and Trojanowski J.Q. Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease. Arch. Neurol. 59 (2002) 972-976
86. Rapoport M., Dawson H.N., Binder L.I., Vitek M.P., and Ferreira A. Tau is essential to beta -amyloid-induced neurotoxicity. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 6364-6369
87. Refolo L.M., Malester B., LaFrancois J., Bryant-Thomas T., Wang R., Tint G.S., Sambamurti K., Duff K., and Pappolla M.A. Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol. Dis. 7 (2000) 321-331
88. Refolo L.M., Pappolla M.A., LaFrancois J., Malester B., Schmidt S.D., Thomas-Bryant T., Tint G.S., Wang R., Mercken M., Petanceska S.S., and Duff K.E. A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease. Neurobiol. Dis. 8 (2001) 890-899
89. Richardson U.I., and Wurtman R.J. Polyunsaturated fatty acids stimulate phosphatidylcholine synthesis in PC12 cells. Biochim. Biophys. Acta. 1771 (2007) 558-563
90. Sakamoto T., Cansev M., and Wurtman R.J. Oral supplementation with docosahexanoic acid and uridine-5′-monophosphate increases dendritic spine density in adult gerbil hippocampus. Brain Res. 1182 (2007) 50-59
91. Saletti A., Lindgren E.Y., Johansson L., and Cederholm T. Nutritional status according to mini nutritional assessment in an institutionalized elderly population in Sweden. Gerontology. 46 (2000) 139-145
92. Sandman P.O., Adolfsson R., Nygren C., Hallmans G., and Winblad B. Nutritional status and dietary intake in institutionalized patients with Alzheimer's disease and multiinfarct dementia. J. Am. Geriatr. Soc. 35 (1987) 31-38
93. Sano M., Ernesto C., Thomas R.G., Klauber M.R., Schafer K., Grundman M., Woodbury P., Growdon J., Cotman C.W., Pfeiffer E., Schneider L.S., and Thal L.J. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N. Engl. J. Med. 336 (1997) 1216-1222
94. Scarmeas N., Luchsinger J.A., Mayeux R., and Stern Y. Mediterranean diet and Alzheimer disease mortality. Neurology. 69 (2007) 1084-1093
95. Scheff S.W., Price D.A., Schmitt F.A., DeKosky S.T., and Mufson E.J. Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology. 68 (2007) 1501-1508
96. Schubert M., Gautam D., Surjo D., Ueki K., Baudler S., Schubert D., Kondo T., Alber J., Galldiks N., Kustermann E., Arndt S., Jacobs A.H., Krone W., Kahn C.R., and Bruning J.C. Role for neuronal insulin resistance in neurodegenerative diseases. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 3100-3105
97. Selkoe D.J. Alzheimer's disease is a synaptic failure. Science. 298 (2002) 789-791
98. Seshadri S., Beiser A., Selhub J., Jacques P.F., Rosenberg I.H., D'Agostino R.B., Wilson P.W., and Wolf P.A. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N. Engl. J. Med. 346 (2002) 476-483
99. Simpson I.A., Carruthers A., and Vannucci S.J. Supply and demand in cerebral energy metabolism: the role of nutrient transporters. J. Cereb. Blood Flow Metab. 20 (2007) 1-26
100. Slack B.E., and Wurtman R.J. Regulation of synthesis and metabolism of the amyloid precursor protein by extracellular signals. Rec. Prog. in Alzheimer Disease and Dementia 2 (2007) 1-25
101. Small G.W., Kepe V., Ercoli L.M., Siddarth P., Bookheimer S.Y., Miller K.J., Lavretsky H., Burggren A.C., Cole G.M., Vinters H.V., Thompson P.M., Huang S.C., Satyamurthy N., Phelps M.E., and Barrio J.R. PET of brain amyloid and tau in mild cognitive impairment. N. Engl.J. Med. 355 (2006) 2652-2663
102. Soderberg M., Edlund C., Kristensson K., and Dallner G. Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease. Lipids 26 (1991) 421-425
103. Solfrizzi V., Colacicco A.M., D'Introno A., Capurso C., Del Parigi A., Capurso S.A., Argentieri G., Capurso A., and Panza F. Dietary fatty acids intakes and rate of mild cognitive impairment. The Italian Longitudinal Study on Aging. Exp. Gerontol. 41 (2006) 619-627
104. Solfrizzi V., Colacicco A.M., D'Introno A., Capurso C., Torres F., Rizzo C., Capurso A., and Panza F. Dietary intake of unsaturated fatty acids and age-related cognitive decline: an 8.5-year follow-up of the Italian Longitudinal Study on Aging. Neurobiol. Aging. 27 (2006) 1694-1704
105. Sommer B.R., Hoff A.L., and Costa M. Folic acid supplementation in dementia: a preliminary report. J. Geriatr. Psychiatry Neurol. 16 (2003) 156-159
106. Sorrentino G., and Bonavita V. Neurodegeneration and Alzheimer's disease: the lesson from tauopathies. Neurol. Sci. 28 (2007) 63-71
107. Spittaels K., Van den Haute C., Van Dorpe J., Bruynseels K., Vandezande K., Laenen I., Geerts H., Mercken M., Sciot R., Van Lommel A., Loos R., and Van Leuven F. Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. Am. J. Pathol. 155 (1999) 2153-2165
108. Steen E., Terry B.M., Rivera E.J., Cannon J.L., Neely T.R., Tavares R., Xu X.J., Wands J.R., and de la Monte S.M. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease-is this type 3 diabetes?. J. Alzheimers Dis. 7 (2005) 63-80
109. Stillwell W., Shaikh S.R., Zerouga M., Siddiqui R., and Wassall S.R. Docosahexaenoic acid affects cell signaling by altering lipid rafts. Reprod. Nutr. Dev. 45 (2005) 559-579
110. Stott D.J., MacIntosh G., Lowe G.D., Rumley A., McMahon A.D., Langhorne P., Tait R.C., O'Reilly D.S., Spilg E.G., MacDonald J.B., MacFarlane P.W., and Westendorp R.G. Randomized controlled trial of homocysteine-lowering vitamin treatment in elderly patients with vascular disease. Am. J. Clin. Nutr. 82 (2005) 1320-1326
111. Sung S., Yao Y., Uryu K., Yang H., Lee V.M., Trojanowski J.Q., and Pratico D. Early vitamin E supplementation in young but not aged mice reduces Abeta levels and amyloid deposition in a transgenic model of Alzheimer's disease. Faseb J. 18 (2004) 323-325
112. Svennerholm L., and Gottfries C.G. Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II). J. Neurochem. 62 (1994) 1039-1047
113. Teather L.A., and Wurtman R.J. Chronic administration of UMP ameliorates the impairment of hippocampal-dependent memory in impoverished rats. J. Nutr. 136 (2006) 2834-2837
114. Terano T., Fujishiro S., Ban T., Yamamoto Y., Tanaka T., Noguchi Y., Tamura Y., Yazawa K., and Hirayama T. Docosahexaenoic acid supplementation improves the moderately severe dementia from thrombotic cerebrovascular diseases. Lipids. 34 (1999) S345-S346
115. Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., Hansen L.A., and Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30 (1991) 572-580
116. Tong X.K., and Hamel E. Regional cholinergic denervation of cortical microvessels and nitric oxide synthase-containing neurons in Alzheimer's disease. Neuroscience. 92 (1999) 163-175
117. Tsai J., Grutzendler J., Duff K., and Gan W.B. Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches. Nat. Neurosci. 7 (2004) 1181-1183
118. Tully A.M., Roche H.M., Doyle R., Fallon C., Bruce I., Lawlor B., Coakley D., and Gibney M.J. Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case-control study. Br. J. Nutr. 89 (2003) 483-489
119. Ulus I.H., Watkins C.J., Cansev M., and Wurtman R.J. Cytidine and uridine increase striatal CDP-choline levels without decreasing acetylcholine synthesis or release. Cell Mol. Neurobiol. 26 (2006) 563-577
120. Ulus I.H., Wurtman R.J., Mauron C., and Blusztajn J.K. Choline increases acetylcholine release and protects against the stimulation-induced decrease in phosphatide levels within membranes of rat corpus striatum. Brain Res. 484 (1989) 217-227
121. van der Beek E.M., Kuipers A.A.M., Leenders I., Broersen L.M., Kamphuis P.J., and De Wilde M.C. Dietary intervention improves cholinergic function. Soc. Neurosci. Abstr. 467 (2006) 13
122. van Dooren T., Dewachter I., Borghgraef P., and van Leuven F. Transgenic mouse models for APP processing and Alzheimer's disease: early and late defects. Subcell Biochem. 38 (2005) 45-63
123. Van Dyk K., and Sano M. The impact of nutrition on cognition in the elderly. Neurochem. Res. 32 (2007) 893-904
124. van Gelder B.M., Tijhuis M., Kalmijn S., and Kromhout D. Fish consumption, n-3 fatty acids, and subsequent 5-y cognitive decline in elderly men: the Zutphen Elderly Study. Am. J. Clin. Nutr. 85 (2007) 1142-1147
125. Vaucher E., and Hamel E. Cholinergic basal forebrain neurons project to cortical microvessels in the rat: electron microscopic study with anterogradely transported Phaseolus vulgaris leucoagglutinin and choline acetyltransferase immunocytochemistry. J. Neurosci. 15 (1995) 7427-7441
126. Velliquette R.A., O'Connor T., and Vassar R. Energy inhibition elevates beta-secretase levels and activity and is potentially amyloidogenic in APP transgenic mice: possible early events in Alzheimer's disease pathogenesis. J. Neurosci. 25 (2005) 10874-10883
127. Walsh D.M., and Selkoe D.J. Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron. 44 (2004) 181-193
128. Wang L., Albrecht M.A., and Wurtman R.J. Dietary supplementation with uridine-5′-monophosphate (UMP), a membrane phosphatide precursor, increases acetylcholine level and release in striatum of aged rat. Brain Res. 1133 (2007) 42-48
129. Weih M., Wiltfang J., and Kornhuber J. Non-pharmacologic prevention of Alzheimer's disease: nutritional and life-style risk factors. J. Neural. Transm. 8 (2007) 1187-1197
130. Wurtman, R.J., Cansev, M., Sakamoto, T., Ulus, I.H., in press. Oral administration of circulating precursors for membrane phosphatides can promote the synthesis of new brain synapses.
131. Wurtman, R.J., Cansev, M., Ulus, I.H., in press. Choline and its products acetylcholine and phosphatidylcholine. Handbook of Neurochemistry 8, chapter 3.2.
132. Wurtman R.J., Ulus I.H., Cansev M., Watkins C.J., Wang L., and Marzloff G. Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally. Brain Res. 1088 (2006) 83-92
133. Ximenes da Silva A., Lavialle F., Gendrot G., Guesnet P., Alessandri J.M., and Lavialle M. Glucose transport and utilization are altered in the brain of rats deficient in n-3 polyunsaturated fatty acids. J. Neurochem. 81 (2002) 1328-1337
134. Yehuda S., Rabinovitz S., Carasso R.L., and Mostofsky D.I. The role of polyunsaturated fatty acids in restoring the aging neuronal membrane. Neurobiol. Aging 23 (2002) 843-853
135. Zhu X., Smith M.A., Honda K., Aliev G., Moreira P.I., Nunomura A., Casadesus G., Harris P.L., Siedlak S.L., and Perry G. Vascular oxidative stress in Alzheimer disease. J. Neurol. Sci. 257 (2007) 240-246
136. Zinser E.G., Hartmann T., and Grimm M.O. Amyloid beta-protein and lipid metabolism. Biochim. Biophys. Acta 1768 (2007) 1991-2001